pressreleases

Purpose Investments and HANetf List First Medical Cannabis UCITS On London Stock Exchange | CBDX

• The Medical Cannabis and Wellness UCITS ETF (CBDX) is the first medical cannabis focused ETF to be listed on London Stock Exchange
• CBDX is listing in the UK with a Total Expense Ratio (TER) of 80bps
• A EUR version – CBSX - was listed in Germany on XETRA earlier this month
• The UK is the world’s largest producer and exporter of legal cannabis for medical and scientific uses [1]
• Purpose is the first Canadian ETF provider to sponsor an ETF on the HANetf platform

London, 20 January, 2020: HANetf is delighted to announce that, together with Canadian based asset manager, Purpose Investments, they are launching The Medical Cannabis and Wellness UCITS ETF (CBDX) on London Stock Exchange.

CBDX is listing on the London Stock Exchange on 22nd January, having already premiered on Deutsche Boerse earlier this month. It is the first and only European UCITS ETF to deliver targeted exposure to the rapidly expanding medical cannabis industry. CBDX is domiciled in Ireland and has also been passported for sale into Italy.

The listing is significant as it provides UK investors with the ability to gain exposure to the fast-growing medical cannabis sector via a transparent, diversified and rigorously screened basket of legal cannabis, hemp and CBD-related securities. In Europe there are now 28 countries [2] with some form of medical cannabis legislation, with the UK being the largest producer and exporter of medical grade cannabis in the world [3]. As of 2018, the global medical cannabis market size was US$ 13.4 Billion. Experts predict that the market is expected to reach a value of US$ 148 Billion by 2026, exhibiting a CAGR of 26.4% [4].

Ivan Gilmore, Head of Exchange Traded Products & Global Product Development, London Stock Exchange plc, commented: “We congratulate HANetf and Purpose Investments on the launch of their ETF, the first for Purpose Investments on London Stock Exchange. As the ETF market and passive investment strategies continue to grow in popularity, innovation is key to providing investors with choice and diversification for their portfolios. The expansion of products, asset class and geographic reach available through ETFs is a positive growth trend. London Stock Exchange is a leading ETF trading venue in Europe and will continue to work with market participants to bring new issuers and innovative funds to market.”

Purpose Investments are a leading Canadian ETF & asset management company with over $8bn (CAD) in assets under management (AuM) as of December 2019 across a range of ETFs and traditional funds. Purpose Investments launched a cannabis fund in Canada in 2017, the Purpose Marijuana Opportunities Fund, and have a have a deep understanding of this exciting, high growth industry sector.

Som Seif, CEO of Purpose Investments commented: “The medical cannabis industry was pioneered in Canada, and we’re thrilled with the opportunity to partner with HANetf to take what we have learned from our Purpose Marijuana Opportunities Fund (MJJ) to Europe. We believe that the cannabis sector is still in the infancy stages of a multi-year growth phase and that there is ample opportunity for innovation and new discoveries. We are very excited to embark on this journey with HANetf in a global investor market.”

Tracking the rules-based Medical Cannabis and Wellness Equity Index provided by world leading thematic index provider Solactive, the CBDX ETF consists of publicly listed companies conducting legal business activities in the medical cannabis, hemp and CBD industry across 9 thematic sub-sectors:

• Producers and suppliers of medical cannabis 
• CBD focused biotech companies 
• Hydroponics and equipment suppliers 
• Producers of medical cannabis consumer products 
• Companies leasing property to medical cannabis growers 
• Software solutions for medical cannabis producers
• Companies with an investment focus on medical cannabis 
• Hemp and CBD consumer goods suppliers 
• Service providers, including equipment, manufacturing and processing 

The constituents go through an in-depth legal, due diligence process and only include equities listed on major stock exchanges such as the NYSE, Nasdaq and TSX.

The fund is fully physically replicated with a TER of 80 bps. As with all ETFs, your capital is at risk.

Hector McNeil, co-Founder and co-CEO at HANetf, said “We are very pleased to be the first firm to bring a medical cannabis listing to the London Stock Exchange. This further expands the range of funds on the HANetf platform which target long-term, transformational themes. We are continuing to work with new partners to help them bring their own thematic strategies to European stock markets and the wider investor universe"

Find out more:

Fund Page: The Medical Cannabis and Wellness UCITS ETF